SNY vs. JNJ
Compare and contrast key facts about Sanofi (SNY) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or JNJ.
Correlation
The correlation between SNY and JNJ is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. JNJ - Performance Comparison
Key characteristics
SNY:
-0.24
JNJ:
-0.51
SNY:
-0.21
JNJ:
-0.66
SNY:
0.98
JNJ:
0.92
SNY:
-0.25
JNJ:
-0.44
SNY:
-0.58
JNJ:
-1.16
SNY:
9.36%
JNJ:
6.81%
SNY:
22.28%
JNJ:
15.39%
SNY:
-46.65%
JNJ:
-52.60%
SNY:
-15.65%
JNJ:
-15.52%
Fundamentals
SNY:
$123.78B
JNJ:
$349.03B
SNY:
$1.85
JNJ:
$6.05
SNY:
26.69
JNJ:
23.96
SNY:
0.87
JNJ:
0.87
SNY:
$36.66B
JNJ:
$66.30B
SNY:
$25.74B
JNJ:
$45.96B
SNY:
$9.62B
JNJ:
$22.61B
Returns By Period
In the year-to-date period, SNY achieves a 2.36% return, which is significantly higher than JNJ's 0.24% return. Over the past 10 years, SNY has underperformed JNJ with an annualized return of 4.19%, while JNJ has yielded a comparatively higher 6.28% annualized return.
SNY
2.36%
7.58%
-1.67%
-4.25%
2.30%
4.19%
JNJ
0.24%
0.78%
-5.96%
-6.83%
2.24%
6.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. JNJ — Risk-Adjusted Performance Rank
SNY
JNJ
SNY vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. JNJ - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.13%, more than JNJ's 3.39% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | 4.13% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
Johnson & Johnson | 3.39% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
SNY vs. JNJ - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for SNY and JNJ. For additional features, visit the drawdowns tool.
Volatility
SNY vs. JNJ - Volatility Comparison
Sanofi (SNY) has a higher volatility of 9.06% compared to Johnson & Johnson (JNJ) at 5.21%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities